




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
Endometriosis
&Adenomyosis
Zhaoaimin
M.D.,Ph.D.,ProfessorDepartmentOfObstetrics&GynecologyRenjiHospitalAffiliatedtoSJTUSchoolofMedicine1Endometriosis
&AdenomEndometriosis2Endometriosis2Definition:Abnormalgrowthofendometrialtissueoutsidetheuterinecavity.3Definition:3IncidenceandPrevalence:IncreasesignificantlyRangefrom1~50%Generalpopulation:1~2%Infertilewomen:30~50%Occursprimarilyinwomenin25~45s4IncidenceandPrevalence:IncrePathogenesis:ImplantationTheoryRetrogradeMenustrationTheorySampson,1921LymphaticandVascularDisseminationTheoryJavert,1952CoelomicTheoryMeyerGeneticTheoryImmuneSystemDysfunction(immunologictheory)5Pathogenesis:ImplantationTheGeneticfactors:Familialclusteringofendometriosisisacommonclinicalobservation.Infamilieswithendometriosis,thediseaseisoftenconfinedtothematernalline,andis7timesmorecommoninfirst-degreerelativesthaninthegeneralpopulation.Infuturestudies,evaluationofDNApolymorphismmayidentifyspecificgenesinvolvedinthedevelopmentofendometriosis.6Geneticfactors:FamilialclustImmunologicTheory:LosecontrolofimmunologicbalanceBothcellularimmunityandhumoralimmunitychange.Macrophage↑releaseIL–1、IL–6、TNF、EGF、FGFetc.stimulateT、BlymphocyteproliferationandactivationActivityofkillercell(NKcellandTcell)↓
Produceanti–endometriumantibodyAbnormalexpressionofCAMs(celladhesionmolecules)7ImmunologicTheory:LosecontroThepathogenesisisunclear.multifactor8Thepathogenesisisunclear.8Pathology
–
macroscopicappearance(1):Thecommonestsites:Ovary(chocolatecyst)Peritoneumoftherecto–vaginalcul–de–sacofthePouchofDouglasUtero–sacralligamentsSigmoidcolonBroadligament9Pathology
–macroscopicappe
Thisisasectionthroughanenlarnged12cmovarytodemonstrateacysticcavityfilledwitholdbloodtypicalforendometriosiswithformationofanendometriotic,or"chocolate",cyst.10101111Pathology
–macroscopicappearance(2):Lesscommonsites:CervixRoundligamentUrinarysystem(bladder、ureter)UmbilicusAppendixLaparotomyscars12Pathology
–macroscopicappeaMultipleappearancesof
endometriosis
implants:Brownish,discoloredperitoneumSuperficialperitonealecchymosisRaised,reddish,superficialnodulesReddish–blueinvasivenodulesFibrotic,whitishnodulesRaised,glossy,translucentblobsPatchy,whiteopacifiedperitoneumReddishorbluishovariancysts13Multipleappearancesofendome
Grossly,inareasofendometriosisthebloodisdarkerandgivesthesmallfociofendometriosisthegrossappearanceof"powderburns".SmallfociareseenherejustundertheserosaoftheposterioruterusinthepouchofDouglas.Suchareasofendometriosiscanbeseenandobliteratedbycauterizationvialaparoscopy.1414Uponcloserview,thesefivesmallareasofendometriosishaveareddish-browntobluishappearance.1515Pathology
–microscopicappearanceHistomorphologicallysimilartoeutopicendometriumFourmajorcomponents:endometrialglandsendometrialstromafibrosishemorrhageEctopicendometrium異位子宮內(nèi)膜Eutopicendometrium在位子宮內(nèi)膜16Pathology
–microscopicapClinicalManifestation17ClinicalManifestation17Symptoms:PainprogressivedysmenorrheadyspareuniapainfuldefecationMenstrualdisturbanceinfertilitydysmenorrhea痛經(jīng)dyspareunia性交痛18Symptoms:PaindysmenorrheadyspaSigns:Enlargementoftheovaries,fixedFixedretroversionoftheuterusTendernoduleswithinthepelvisCannotbediagnosedbyPValone.Shouldalwaysbeconsideredwhenpatientshavesymptomsreferabletothepelviccavity.19Signs:EnlargementoftheovariVeryvariableVarywiththefocuslocationOftenbearnorelationtotheextentofthediseaseQuiteoftendepositsarefoundincidentallyinwomenwhohavenosymptoms.(25%havenosymptoms)20Veryvariable20Diagnosis:HistoryPVexaminationLaparoscopy(goldenstandard)Ultrasonography(B–typeultrasound)CA–125↑(<200U/ml;normalvalue35U/ml)Anti–endometriumantibody(+)21Diagnosis:History21Stagingsystems:IntheAFS-r(1985)stagingsystem,pointsareassignedforseverityofendometriosisbasedonthesizeanddepthoftheimplantandfortheseverityofadhesions.Thepointsaresummedandthepatientsareassignedtoonetofourstages:StageI—minimaldisease,1~5pointsStageII—milddisease,6~15pointsStageIII—moderatedisease,16~40pointsStageIV—severedisease,≥40points22Stagingsystems:IntheAFS-r(1Differentialdiagnosis:MalignantovarytumoursPelvicinflammatorymassesAdenomyosis23Differentialdiagnosis:MalignaTreatment24Treatment24Expectanttherapy:Indications:withverylimiteddisease(whosesymptomsareminimalornonexistent)Iftryingtogetpregnant,thebestwayistoacceptlaparoscopictherapyasearlyaspossible.25Expectanttherapy:Indications:Medicaltherapy:Indications:chronicpelvicpainseveredysmenorrheanorequiretogetpregnantnoovariancystformationHormone–inhibitiontherapy26Medicaltherapy:Indications:chDrugs:Danazol:pseudomenopausetherapyGestrinoneGnRH–a:medicaloophorectomyadd–backtherapyMifepristoneRU486Progestogens:pseudopregnancytherapy27Drugs:Danazol:pseudomenopauseSurgicaltherapy(1):Indications(1)adnexalmass(2)pelvicpain(3)infertilityApproaches:(1)trans–abdominal(2)laparoscopic28Surgicaltherapy(1):IndicationSurgicaltherapy(2):Methods:ConservativesurgerypreservethefecunditypreservetheovarianfunctionDefinitivesurgery:hysterectomy+salpingo–oophorectomy29Surgicaltherapy(2):Methods:29Combination
medical–surgicaltreatment:Three–step:
surgerymedicaltherapysecondlook(laparoscopy)30Combination
medical–surgicalItisimportanttoindividualizethechoiceoftherapy.Therapymustbetailoredto
thedegreeofsymptomatologythepatient’sageherdesiretomaintainfertility31ItisimportanttoindividualPrognosis:Withpropertreatment,theprognosisisgoodforreliefofpainandenhancementoffertilityinmildtomoderateendometriosis.Inmostcases,hormonaltherapyistemporarilyeffectiveincontrollingsymptomsandarrestinggrowthbutisgenerallylesseffectivethansurgeryinincreasingfertility.Therecurrentrateisveryhigh.32Prognosis:32Prevention:Avoidpossibleaugmentationofmenstrualreflux.Takingoralcontraceptiveisrecommended.Isolationandirrigationoftheoperativesite.33Prevention:AvoidpossibleaugmCritical
points(1):Thepathogenesisispoorlyunderstood,butemergingevidencesupportsthecausativeroleofretrogrademenstruationandimplantationofendometrialtissue.Endometriosisisacommoninwomenwithpelvicpainorinfertility.Laparoscopyistheoptimaltechniquetodiagnosepelvicendometriosis.34Criticalpoints(1):ThepathogeCritical
points(2):Inmostcases,surgicaltherapyatthetimeofinitialdiagnosiseffectivelyrelievespainandmayenhancefertility.Alternatively,medicaltherapywithprogestins、danazol、gestrinoneorGnRH-awillamelioratepelvicpain,buttheydonotenhancefertility.Endometriosisisarecurrentdisease,anddefinitivetreatmentwithremovalofpelvicorgansmaybenecessary.35Criticalpoints(2):InmostcasAdenomyosis36Adenomyosis36Definition:
Abenignuterineconditioninwhichendometrialglandsandstromaarefounddeepinthemyometrium.37Definition:AbenignuterineEtiology:Basalendometrialhyperplasiainvadingahyperplasticmyometrialstroma.Fourprimarytheories:HeredityTraumaHyperestrogenemiaViraltransmission38Etiology:BasalendometrialhypPathology
—grossappearance:UsuallyhyperemicwiththickenedwallsThefociarefrequentlyscattereddiffuselythroughoutthemyometrium.Occasionally,maybemorecircumscribed,withtheformationofadistinctnodule,anadenomyoma.Adenomyosis子宮肌腺癥Adenomyoma子宮肌腺瘤39Pathology
—grossappearan
Thethickenedandspongyappearingmyometrialwallofthissectioneduterusistypicalofadenomyosis.Thereisalsoasmallwhiteleiomyomaatthelowerleft.4040Clinicalfeatures(1):Symptomaticadenomyosisoccursprimarilyinparouswomenovertheageof40.(30~50)Classicsymptoms:
secondarydys
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2024年紡織設(shè)計(jì)師設(shè)計(jì)練習(xí)試題及答案
- 服務(wù)人員管理試題及答案
- 紡織品設(shè)計(jì)中的創(chuàng)意思維考核試題及答案
- 2024年紡織工程師服裝設(shè)計(jì)試題及答案
- 《工程繪圖入門教程》課件
- 提升高校學(xué)生醫(yī)療保障質(zhì)量的行動(dòng)計(jì)劃
- 廣告設(shè)計(jì)師如何形成設(shè)計(jì)思路 試題及答案
- 《螺絲的基礎(chǔ)知識(shí)》課件
- 衛(wèi)生計(jì)生監(jiān)督試題及答案
- 廣告設(shè)計(jì)師傳播心理學(xué)應(yīng)用試題及答案
- (三模)合肥市2025屆高三年級(jí)5月教學(xué)質(zhì)量檢測(cè)政治試卷(含答案解析)
- 生物+昆一中2025屆高三聯(lián)考試卷及答案(九)
- 陜西、山西省天一大聯(lián)考2024-2025學(xué)年高中畢業(yè)班階段性測(cè)試(七)語文試題及答案
- 《油氣井套管工程檢測(cè)技術(shù)》課件
- 大學(xué)生就業(yè)去向論文
- 2025屆高考語文復(fù)習(xí):2024年新課標(biāo)二卷第九題說題 課件
- 2024年鐵總服務(wù)有限公司招聘筆試真題
- 職業(yè)技術(shù)學(xué)院2024級(jí)安全技術(shù)與管理專業(yè)人才培養(yǎng)方案
- 微專業(yè)課程體系構(gòu)建研究-全面剖析
- 運(yùn)動(dòng)素質(zhì)知到課后答案智慧樹章節(jié)測(cè)試答案2025年春浙江大學(xué)
- 湖北武漢市2025屆高三第一次調(diào)研測(cè)試數(shù)學(xué)試卷含解析
評(píng)論
0/150
提交評(píng)論